Cargando…
Gain-of-function mutations in the catalytic domain of DOT1L promote lung cancer malignant phenotypes via the MAPK/ERK signaling pathway
Lung cancer is a lethal malignancy lacking effective therapies. Emerging evidence suggests that epigenetic enzyme mutations are closely related to the malignant phenotype of lung cancer. Here, we identified a series of gain-of-function mutations in the histone methyltransferase DOT1L. The strongest...
Autores principales: | Zhang, Jiayu, Yang, Ting, Han, Mei, Wang, Xiaoxuan, Yang, Weiming, Guo, Ning, Ren, Yong, Cui, Wei, Li, Shangxiao, Zhao, Yongshan, Zhai, Xin, Jia, Lina, Yang, Jingyu, Wu, Chunfu, Wang, Lihui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413674/ https://www.ncbi.nlm.nih.gov/pubmed/37256945 http://dx.doi.org/10.1126/sciadv.adc9273 |
Ejemplares similares
-
Edge modification facilitated heterogenization and exfoliation of two-dimensional nanomaterials for cancer catalytic therapy
por: Chen, Liqun, et al.
Publicado: (2022) -
An MKP-MAPK protein phosphorylation cascade controls vascular immunity in plants
por: Lin, Hui, et al.
Publicado: (2022) -
Pronounced sequence specificity of the TET enzyme catalytic domain guides its cellular function
por: Ravichandran, Mirunalini, et al.
Publicado: (2022) -
MAPK6-AKT signaling promotes tumor growth and resistance to mTOR kinase blockade
por: Cai, Qinbo, et al.
Publicado: (2021) -
Genome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response
por: Wang, Yifei, et al.
Publicado: (2022)